Dambkowski Carl
- SEC CIK
- 0001983476
In the past year, 14 open-market sale filings worth $18.8M and no purchases.
Current role at each company
- APGE Apogee Therapeutics, Inc.Chief Medical Officeras of Sep 3, 2026
- ORKA Oruka Therapeutics, Inc.Directoras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $18.8M
- 14 filings
- Net
- −$18.8M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Dambkowski Carl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APGE Apogee Therapeutics, Inc.
Chief Medical Officer28 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 (view filing) | Jul 3 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −6.00K | $37.60 | −$225.4K | −2.0%294.8K after | 2 lots10b5-1 |
| Aug 9, 2024 (view filing) | Aug 7 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −7.33K | $40.67 | −$298.3K | −2.5%287.5K after | 3 lots10b5-1 |
| Sep 6, 2024 (view filing) | Sep 4 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −6.67K | $47.56 | −$317.0K | −2.3%280.8K after | 2 lots10b5-1 |
| Oct 4, 2024 (view filing) | Oct 2 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −6.67K | $56.26 | −$375.0K | −2.4%274.1K after | 2 lots10b5-1 |
| Nov 8, 2024 (view filing) | Nov 6 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −6.67K | $59.12 | −$394.0K | −2.4%267.5K after | 2 lots10b5-1 |
| Dec 6, 2024 (view filing) | Dec 4 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −6.67K | $46.07 | −$307.1K | −2.5%260.8K after | 10b5-1 |
| Dec 13, 2024 (view filing) | Dec 11 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −4.54K | $48.76 | −$221.4K | −1.7%258.1K after | 2 lots10b5-1 |
| Jan 3, 2025 (view filing) | Jan 2 | 1 day | Dambkowski CarlChief Medical Officer | SSale | −4.08K | $46.94 | −$191.7K | −1.6%255.3K after | 3 lots10b5-1 |
| Feb 7, 2025 (view filing) | Feb 5 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −3.52K | $40.69 | −$143.2K | −1.4%252.6K after | 10b5-1 |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −1.59K | $30.48 | −$48.5K | −0.6%251.0K after | 10b5-1 |
ORKA Oruka Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 (view filing) | May 21 | 1 day | Dambkowski CarlDirector | SSale | −105.0K | $58.97 | −$6.19M | −58.7%73.7K after | 3 lots10b5-1 |
| Jun 12, 2026 (view filing) | Jun 11-12 | 1 day | Dambkowski CarlDirector | SSale | −35.0K | $70.12 | −$2.45M | −47.5%38.7K after | 2 lots10b5-1 |